Mixed options sentiment in Novo Nordisk (NVO), with shares up $1.85, or 4.0%, near $48.22. Options volume roughly in line with average with 31k contracts traded and calls leading puts for a put/call ratio of 0.33, compared to a typical level near 0.55. Implied volatility (IV30) dropped 0.46 near 36.3,in the lowest 10% of observations over the past year, suggesting an expected daily move of $1.10. Put-call skew steepened, indicating increased demand for downside protection, following a downgrade to Hold at Argus.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Lexicon announces publication of preclinical data on ACSL5
- Hims & Hers Health (HIMS) Bolsters UK Business with Launch of Weight-Loss Plans
- Novo Nordisk price target raised to $54 from $47 at HSBC
- Structure Therapeutics Stock (GPCR) Spikes 102% as Obesity Trial Beats Eli Lilly, Novo Nordisk
- Mixed options sentiment in Novo Nordisk with shares down 0.27%